Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud

  • Karen Huaman Sanchez
  • , Fabiola Huaroto
  • , Catherine Bonilla
  • , Adolfo Aramburú
  • , Javier Morales Barrenechea
  • , Ericson L. Gutiérrez
  • , Maricela Curisinche
  • , Daniel Rojas Bolivar
  • , Diana Maria Gonzales Zurita
  • , Jose Carlos Sánchez-Ramírez
  • , Nora Reyes Puma

Producción científica: Artículo CientíficoArtículo originalrevisión exhaustiva

Resumen

The COVID-19 pandemics required the countries to take decisions rapidly. Consequently, the National Institute of Health (INS) developed a series of documents of scientific evidence synthesis according to the Ministry of Health’s requirements. Based on these reports, the INS developed recommendations to update normative documents related to COVID-19’s management. This article describes the construction of a new methodology applied by the INS to synthesize scientific evidence during the COVID-19 pandemic. Moreover, it emphasizes the efforts and strategies used to guarantee the methodological quality and the implementation of the GRADE approach. Finally, it provides a short reflection on the limitations and challenges of using evidence to design national public policies in the future.

Título traducido de la contribuciónUse of evidence during the COVID-19 pandemic in Peru, contributions from the National Institute of Health
Idioma originalEspañol
PublicaciónRevista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
Volumen15
DOI
EstadoIndizado - set. 2022

Nota bibliográfica

Publisher Copyright:
© 2022 Publicado por Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo.

Palabras clave

  • COVID-19
  • GRADE approach
  • Perú
  • Policy Making
  • evidence-informed policy-making

Huella

Profundice en los temas de investigación de 'Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud'. En conjunto forman una huella única.

Citar esto